Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension

Abstract

Resistant hypertension (RHTN) includes both patients whose blood pressure (BP) is uncontrolled on three or more medications (uncontrolled RHTN (UCRH)) and patients whose BP is controlled with use of four or more drugs (controlled RHTN (CRH)). It is unknown whether endothelial function and nocturnal drop demonstrate a similar pattern in patients with CRH and UCRH. We examined circadian BP patterns and vascular function in these patients. In all, 40 CRH and 26 UCRH patients, and 25 normotensives underwent biochemical testing, ambulatory BP monitoring, determination of brachial artery responses to endothelial-dependent (flow-mediated; dilation (FMD)) and independent (nitroglycerin mediated) stimuli. The nighttime drop in systolic BP (SBP) and diastolic BP (DBP) was less pronounced in UCRH than in CRH (SBP, 1.9±1.6 versus 4.9±1.7%; DBP, 7.5±1.8 versus 10.9±1.8%, UCRH and CRH, respectively; P<0.05). FMD was greater in control group compared with RHTN patients. Patients with UCRH had significantly impaired FMD compared with CRH (5.9±2.3% versus 7.1±5.1%; P<0.0001). Therefore, UCRH patients have less nocturnal dipping and a more impaired endothelial response compared with CRH patients. These findings suggest that important differences among patients with RHTN may allow identify subgroups with increased cardiovascular risk.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4

Similar content being viewed by others

References

  1. Calhoun DA, Jones D, Textor S, Goff DC, Murphy TP, Toto RD et al. Resistant hypertension: diagnosis, evaluation, and treatment: a scientific statement from the American Heart association professional education committee of the council for high blood pressure research. Circulation 2008; 117 (25): e510–e526.

    Article  PubMed  Google Scholar 

  2. Martins LC, Figueiredo VN, Quinaglia T, Boer-Martins L, Yugar-Toledo JC, Martin JFV et al. Characteristics of resistant hypertension: aging, body mass index, hyperaldosteronism, cardiac hypertrophy and vascular stiffness. J Hum Hypertens 2011; 25: 532–538..

    Article  CAS  PubMed  Google Scholar 

  3. Muxfeldt ES, Bloch KV, Nogueira AR, Salles GF . Twenty-four hour ambulatory blood pressure monitoring pattern of resistant hypertension. Blood Press Monit 2003; 8 (5): 181–185.

    Article  PubMed  Google Scholar 

  4. Hermida RC, Ayala DE, Mojón A, Fernández JR . Effects of time of antihypertensive treatment on ambulatory blood pressure and clinical characteristics of subjects with resistant hypertension. Am J Hypertens 2010; 23 (4): 432–439.

    Article  CAS  PubMed  Google Scholar 

  5. Pierdomenico SD, Lapenna D, Bucci A, Di Tommaso R, Di Mascio R, Manente BM et al. Cardiovascular outcome in treated hypertensive patients with responder, masked, false resistant, and true resistant hypertension. Am J Hypertens 2005; 18 (11): 1422–1428.

    Article  PubMed  Google Scholar 

  6. Verdecchia P . Prognostic value of ambulatory blood pressure: current evidence and clinical implications. Hypertension 2000; 35 (3): 844–851.

    Article  CAS  PubMed  Google Scholar 

  7. Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, Tácito LH et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 2004; 125 (3): 823–830.

    Article  PubMed  Google Scholar 

  8. de Souza WA, Yugar-Toledo JC, Bergsten-Mendes G, Sabha M, Moreno Jr H . Effect of pharmaceutical care on blood pressure control and health-related quality of life in patients with resistant hypertension. Am J Health Syst Pharm 2007; 64 (18): 1955–1961.

    Article  PubMed  Google Scholar 

  9. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo Jr JL et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289 (19): 2560–2572.

    Article  CAS  PubMed  Google Scholar 

  10. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340 (8828): 1111–1115.

    Article  CAS  PubMed  Google Scholar 

  11. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39 (2): 257–265.

    Article  PubMed  Google Scholar 

  12. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32 (1): 123–127.

    Article  CAS  PubMed  Google Scholar 

  13. Clement DL, De Buyzere ML, De Bacquer DA, de Leeuw PW, Duprez DA, Fagard RH et al. Prognostic value of ambulatory blood-pressure recordings in patients with treated hypertension. N Engl J Med 2003; 348 (24): 2407–2415.

    Article  PubMed  Google Scholar 

  14. Sega R, Facchetti R, Bombelli M, Cesana G, Corrao G, Grassi G et al. Prognostic value of ambulatory and home blood pressures compared with office blood pressure in the general population: follow-up results from the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) study. Circulation 2005; 111 (14): 1777–1783.

    Article  PubMed  Google Scholar 

  15. Verdecchia P, Schillaci G, Borgioni C, Ciucci A, Pede S, Porcellati C . Ambulatory pulse pressure: a potent predictor of total cardiovascular risk in hypertension. Hypertension 1998; 32 (6): 983–988.

    Article  CAS  PubMed  Google Scholar 

  16. Cuspidi C, Macca G, Sampieri L, Fusi V, Severgnini B, Michev I et al. Target organ damage and non-dipping pattern defined by two sessions of ambulatory blood pressure monitoring in recently diagnosed essential hypertensive patients. J Hypertens 2001; 19 (9): 1539–1545.

    Article  CAS  PubMed  Google Scholar 

  17. Dolan E, Thijs L, Li Y, Atkins N, McCormack P, McClory S et al. Ambulatory arterial stiffness index as a predictor of cardiovascular mortality in the Dublin Outcome Study. Hypertension 2006; 47 (3): 365–370.

    Article  CAS  PubMed  Google Scholar 

  18. Fagard RH, Celis H, Thijs L, Staessen JA, Clement DL, De Buyzere ML et al. Daytime and nighttime blood pressure as predictors of death and cause-specific cardiovascular events in hypertension. Hypertension 2008; 51 (1): 55–61.

    Article  CAS  PubMed  Google Scholar 

  19. Hansen TW, Jeppesen J, Rasmussen S, Ibsen H, Torp-Pedersen C . Ambulatory blood pressure monitoring and risk of cardiovascular disease: a population based study. Am J Hypertens 2006; 19 (3): 243–250.

    Article  PubMed  Google Scholar 

  20. Ohkubo T, Hozawa A, Yamaguchi J, Kikuya M, Ohmori K, Michimata M et al. Prognostic significance of the nocturnal decline in blood pressure in individuals with and without high 24-h blood pressure: the Ohasama study. J Hypertens 2002; 20 (11): 2183–2189.

    Article  CAS  PubMed  Google Scholar 

  21. Verdecchia P, Porcellati C, Schillaci G, Borgioni C, Ciucci A, Battistelli M et al. Ambulatory blood pressure. An independent predictor of prognosis in essential hypertension. Hypertension 1994; 24 (6): 793–801.

    Article  CAS  PubMed  Google Scholar 

  22. Kario K, Pickering TG, Matsuo T, Hoshide S, Schwartz JE, Shimada K . Stroke prognosis and abnormal nocturnal blood pressure falls in older hypertensives. Hypertension 2001; 38 (4): 852–857.

    Article  CAS  PubMed  Google Scholar 

  23. Boggia J, Li Y, Thijs L, Hansen TW, Kikuya M, Björklund-Bodegård K et al. Prognostic accuracy of day versus night ambulatory blood pressure: a cohort study. Lancet 2007; 370 (9594): 1219–1229.

    Article  PubMed  Google Scholar 

  24. Kikuya M, Ohkubo T, Asayama K, Metoki H, Obara T, Saito S et al. Ambulatory blood pressure and 10-year risk of cardiovascular and noncardiovascular mortality: the Ohasama study. Hypertension 2005; 45 (2): 240–245.

    Article  CAS  PubMed  Google Scholar 

  25. Metoki H, Ohkubo T, Kikuya M, Asayama K, Obara T, Hashimoto J et al. Prognostic significance for stroke of a morning pressor surge and a nocturnal blood pressure decline: the Ohasama study. Hypertension 2006; 47 (2): 149–154.

    Article  CAS  PubMed  Google Scholar 

  26. de la Sierra A, Redon J, Banegas JR, Segura J, Parati G, Gorostidi M et al. Prevalence and factors associated with circadian blood pressure patterns in hypertensive patients. Hypertension 2009; 53 (3): 466–472.

    Article  CAS  PubMed  Google Scholar 

  27. Salles GF, Cardoso CR, Muxfeldt ES . Prognostic influence of office and ambulatory blood pressures in resistant hypertension. Arch Intern Med 2008; 168 (21): 2340–2346.

    Article  PubMed  Google Scholar 

  28. Cuspidi C, Macca G, Sampieri L, Michev I, Salerno M, Fusi V et al. High prevalence of cardiac and extracardiac target organ damage in refractory hypertension. J Hypertens 2001; 19 (11): 2063–2070.

    Article  CAS  PubMed  Google Scholar 

  29. Iiyama K, Nagano M, Yo Y, Nagano N, Kamide K, Higaki J et al. Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 1996; 132 (4): 779–782.

    Article  CAS  PubMed  Google Scholar 

  30. Lauer T, Heiss C, Preik M, Balzer J, Hafner D, Strauer BE et al. Reduction of peripheral flow reserve impairs endothelial function in conduit arteries of patients with essential hypertension. J Hypertens 2005; 23 (3): 563–569.

    Article  CAS  PubMed  Google Scholar 

  31. Li J, Zhao SP, Li XP, Zhuo QC, Gao M, Lu SK . Non-invasive detection of endothelial dysfunction in patients with essential hypertension. Int J Cardiol 1997; 61 (2): 165–169.

    Article  CAS  PubMed  Google Scholar 

  32. Taddei S, Virdis A, Ghiadoni L, Sudano I, Salvetti A . Effects of antihypertensive drugs on endothelial dysfunction: clinical implications. Drugs 2002; 62 (2): 265–284.

    Article  CAS  PubMed  Google Scholar 

  33. Ubaid-Girioli S, Adriana de Souza L, Yugar-Toledo JC, Martins LC, Ferreira-Melo S, Coelho OR et al. Aldosterone excess or escape: Treating resistant hypertension. J Clin Hypertens (Greenwich) 2009; 11 (5): 245–252.

    Article  CAS  Google Scholar 

  34. Sowers JR, Whaley-Connell A, Epstein M . Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension. Ann Intern Med 2009; 150 (11): 776–783.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Sozen AB, Kayacan MS, Tansel T, Celebi A, Kudat H, Akkaya V et al. Drugs with blocking effects on the renin-angiotensin-aldosterone system do not improve endothelial dysfunction long-term in hypertensive patients. J Int Med Res 2009; 37 (4): 996–1002.

    Article  CAS  PubMed  Google Scholar 

  36. Kotsis V, Stabouli S, Bouldin M, Low A, Toumanidis S, Zakopoulos N . Impact of obesity on 24-h ambulatory blood pressure and hypertension. Hypertension 2005; 45 (4): 602–607.

    Article  CAS  PubMed  Google Scholar 

  37. Faria AN, Ribeiro Filho FF, Gouveia Ferreira SR, Zanella MT . Impact of visceral fat on blood pressure and insulin sensitivity in hypertensive obese women. Obes Res 2002; 10 (12): 1203–1206.

    Article  PubMed  Google Scholar 

  38. Tartan Z, Uyarel H, Kasikcioglu H, Alper AT, Ozay B, Bilsel T et al. Metabolic syndrome as a predictor of non-dipping hypertension. Tohoku J Exp Med 2006; 210 (1): 57–66.

    Article  PubMed  Google Scholar 

  39. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC . Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 2001; 37 (4): 699–705.

    Article  CAS  PubMed  Google Scholar 

  40. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar RB, Weissmann P . Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 2002; 40 (6): 892–896.

    Article  CAS  PubMed  Google Scholar 

  41. Strauch B, Zelinka T, Hampf M, Bernhardt R, Widimsky Jr J . Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region. J Hum Hypertens 2003; 17 (5): 349–352.

    Article  CAS  PubMed  Google Scholar 

  42. Eide IK, Torjesen PA, Drolsum A, Babovic A, Lilledahl NP . Low-renin status in therapy-resistant hypertension: a clue to efficient treatment. J Hypertens 2004; 22 (11): 2217–2226.

    Article  CAS  PubMed  Google Scholar 

  43. Whaley-Connell A, Johnson MS, Sowers JR . Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis 2010; 52 (5): 401–409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  44. Whaley-Connell A, Johnson MS, Sowers JR . Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis 2010; 52 (5): 401–409.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  45. Cooper SA, Whaley-Connell A, Habibi J, Wei Y, Lastra G, Manrique C . Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. Am J Physiol Heart Circ Physiol 2007; 293 (4): H2009–H2023.

    Article  CAS  PubMed  Google Scholar 

  46. Brown NJ . Aldosterone and vascular inflammation. Hypertension 2008; 51 (2): 161–167.

    Article  CAS  PubMed  Google Scholar 

  47. Wehling M, Christ M, Theisen K . Membrane receptors for aldosterone: a novel pathway for mineralocorticoid action. Am J Physiol 1992; 263 (5 Pt 1): E974–E979.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This study was supported by FAPESP, SP, Brazil. H Moreno Jr, V Nasser Figueiredo and T Quinaglia were supported by Conselho Nacional de Pesquisa (CNPq) and CAPES (Brazil).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to H Moreno Jr.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Quinaglia, T., Martins, L., Figueiredo, V. et al. Non-dipping pattern relates to endothelial dysfunction in patients with uncontrolled resistant hypertension. J Hum Hypertens 25, 656–664 (2011). https://doi.org/10.1038/jhh.2011.43

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/jhh.2011.43

Keywords

This article is cited by

Search

Quick links